Sex-related differences in the efficacy of immune checkpoint inhibitors in malignancy: a systematic review and meta-analysis
Open Access
- 4 June 2021
- journal article
- review article
- Published by Impact Journals, LLC in Aging
- Vol. 13 (11) , 15413-15432
Abstract
Although disease susceptibility is known to differ between men and women, it is controversial whether the efficacy of immune checkpoint inhibitors for malignancies also differs between the sexes. We conducted a meta-analysis to explore the impact of sex on immune checkpoint inhibitor treatment outcomes. We searched PubMed, Embase and the Cochrane Library databases from inception to October 1, 2020 for randomized controlled trials of immune checkpoint inhibitors with hazard ratios (HRs) stratified by sex. We calculated the pooled HRs for men and women using the ln(HR), and assessed the heterogeneity between the two estimates through an interaction test. In total, 22,268 patients from 39 randomized controlled trials were included. Immune checkpoint inhibitors yielded better overall survival than conventional agents in both men (HR: 0.75, 95% confidence interval [CI]: 0.71-0.80) and women (HR: 0.77, 95% CI: 0.70-0.85). Progression-free survival benefits were also observed in both men (HR: 0.64, 95% CI: 0.58-0.70) and women (HR: 0.67, 95% CI: 0.58-0.77) treated with immune checkpoint inhibitors. No sex differences in the response to immune checkpoint inhibitors were found when overall survival and progression-free survival were used as the endpoints.Keywords
This publication has 69 references indexed in Scilit:
- Chromosome Y Regulates Survival Following Murine Coxsackievirus B3 InfectionG3: Genes, Genomes, Genetics, 2012
- Sex Disparities in Cancer Mortality and SurvivalCancer Epidemiology, Biomarkers & Prevention, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- B7-H1–Dependent Sex-Related Differences in Tumor Immunity and Immunotherapy ResponsesThe Journal of Immunology, 2010
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- The X chromosome in immune functions: when a chromosome makes the differenceNature Reviews Immunology, 2010
- Sex differences in the effects of maternal vitamin supplements on mortality and morbidity among children born to HIV-infected women in TanzaniaBritish Journal of Nutrition, 2010
- Sex Disparities in Cancer Incidence by Period and AgeCancer Epidemiology, Biomarkers & Prevention, 2009
- Measuring inconsistency in meta-analysesBMJ, 2003
- Gender Effects in Pharmacokinetics and PharmacodynamicsDrugs, 1995